PBH - PBH プレステ―ジ・コンシュ―マ―・ヘルスケア （）

… the current year. Prestige Consumer Healthcare Company Profile (Get Rating) … segments: North American OTC Healthcare and International OTC Healthcare . The North American … and International OTC Healthcare segments manages the following brands …

… About Prestige Consumer Healthcare (Get Rating) Prestige Consumer Healthcare , Inc engages in … : North American OTC Healthcare and International OTC Healthcare . The North American … and International OTC Healthcare segments manages the following …

Envestnet Asset Management Inc. raised its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) by 3.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 24,598 shares of the company’s stock after buying an additional 869 shares during the period. Envestnet Asset Management Inc.’s holdings in Prestige Consumer Healthcare were worth […]

Prestige Consumer Healthcare Inc. (NYSE:NYSE:PBH) Q4 2023 Results Conference Call May 4, 2023 8:30 AM ETCompany ParticipantsPhil Terpolilli - VP, IR and TreasuryRon Lombardi - CEOChristine…

Companies Reporting Before The Bell • Cedar Fair (NYSE: FUN ) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million. • MGP Ingredients (NASDAQ: MGPI ) is likely to report quarterly earnings at $1.11 per share on revenue of $194.39 million. • Vital Farms (NASDAQ: VITL ) is likely to report quarterly earnings at $0.05 per share on revenue of $103.76 million. • Obsidian Energy (AMEX: OBE ) is projected to report quarterly earnings at $0.39 per share on revenue of $150.00 million. • Blueprint Medicines (NASDAQ: BPMC ) is projected to report quarterly loss at $2.67 per share on revenue of $41.96 million. • Perella Weinberg (NASDAQ: PWP ) is projected to report quarterly earnings at $0.06 per share on revenue of $126.50 million. • Shift4 Payments (NYSE: FOUR ) is estimated to report quarterly earnings at $0.36 per share on revenue of $524.98 million. • PENN Entertainment (NASDAQ: PENN ) is estimated to report quarterly earnings at $0.38 per share on revenue of $1.

Prestige Consumer Healthcare Inc. (NYSE:NYSE:PBH) Q3 2023 Results Conference Call February 2, 2023 8:30 AM ETCompany ParticipantsPhil Terpolilli - Vice President of Investor Relations &…

Global Pregnancy Testing Devices Market Report 2023 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2030 (Based on 2023 COVID-19 Worldwide Spread) is the latest research study released by CMI evaluating the market risk side analysis, highlighting opportunities,

A share of Prestige Consumer Healthcare Inc. (NYSE:PBH) closed at $62.02 per share on Friday, up from $61.94 day before. While Prestige Consumer Healthcare Inc. has overperformed by 0.13%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PBH rose by 0.23%, with highs and lows ranging […]

Prestige Consumer Healthcare Inc. (NYSE:PBH) concluded the trading at $60.61 on Friday, December 16 with a rise of 0.25% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $60.46 and 5Y monthly beta was reading 0.59 with its price kept floating in … New Insight On Prestige Consumer Healthcare Inc. (PBH) Read More »

Related Stocks: PBH ,

TARRYTOWN, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 fourth quarter and year-end earnings release on Thursday, May 5, 2022 after the market close. The following morning, May 6, at 8:30 a.m. ET, the Company will host a conference call to discuss the results as well as for a discussion into the Company’s leading business attributes.

TARRYTOWN, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter ended December 31, 2021.

Prestige Consumer Healthcare Inc (PBH) shares closed today at 1.1% below its 52 week high of $63.83, giving the company a market cap of $3B. The stock is currently up 79.2% year-to-date, up 77.6% over the past 12 months, and up 20.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 57.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 434.2% The company's stock price performance over the past 12 months beats the peer average by 402.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -20.4% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.